This brand name is authorized in Nigeria.
The drug FEVAGRIP contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
362O9ITL9D - ACETAMINOPHEN
|
|
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
|
2
|
UNII
3G6A5W338E - CAFFEINE
|
|
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
|
3
|
UNII
04JA59TNSJ - PHENYLEPHRINE HYDROCHLORIDE
|
|
Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion. |
|
4
|
UNII
V1Q0O9OJ9Z - CHLORPHENIRAMINE MALEATE
|
|
Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-5729 | Caplet | FEVAGRIP CAPLETS TAB 325 mg; 30 mg; 5 mg; 2 mg 25X4 | 21 RNW-PP-166269 FEVAGRIP CAPLETS PARACETAMOL, CAFFEINE, PHENYLEPHRINE GCL, CHLORPHENIRAMINE MALEATE EAC UNCOATED TABLET CONTAINS: PARACETAMOL B.P. 325 MG, CAFFEINE (ANHYDROUS) B.P. 30 MG., PHENYLEPHRINE HCL B.P. 5 MG., CHLORPHENIRAMINE MALEATE B.P. 2 MG, EXCIPIENTS ....Q.S. B4-5729 Drugs Imported Products 25X4 Over The Counter (OTC) 10/14/2020 EZECHUKS PHARMACEUTICALS COY. LIMITED., SAM EZECHUKU CLOSE OFF OSADENIS HIGH SCHOOL ROAD, ASABA. DELTA 8027817642 ezechukspharmltd@gmail.com M/S LESANTO LABORATORIES , PLOT 9,10,11 & 20, SURVEY NO 53, J.B UDYOG NAGAR, NEAR MANOR RAILWAY BRIDGE PALGHAR (EAST] MAHARASHTRA STATE INDIA, India | 31/10/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R01BA53 | Phenylephrine, combinations | R Respiratory system → R01 Nasal preparations → R01B Nasal decongestants for systemic use → R01BA Sympathomimetics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-5729 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.